Factors associated with progression to inflammatory arthritis in first-degree relatives of individuals with RA following autoantibody positive screening in a non-clinical setting

关节炎 免疫学 痹症科 银屑病性关节炎 抗体 临床意义 队列
作者
Elizabeth A. Bemis,M. Kristen Demoruelle,Jennifer Seifert,Kristen J. Polinski,Michael H. Weisman,Jane H. Buckner,Peter K. Gregersen,Ted R. Mikuls,James R. O'Dell,Richard M. Keating,Kevin D. Deane,V. Michael Holers,Jill M. Norris
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:80 (2): 154-161 被引量:7
标识
DOI:10.1136/annrheumdis-2020-217066
摘要

Objectives Little is known about the likelihood of developing inflammatory arthritis (IA) in individuals who screen autoantibody positive (aAb+) in a non-clinical research setting. Methods We screened for serum cyclic citrullinated peptide antibody (anti-CCP) and rheumatoid factor isotype aAbs in subjects who were at increased risk for rheumatoid arthritis (RA) because they are a first-degree relative of an individual with classified RA (n=1780). We evaluated combinations of aAbs and high titre aAbs, as defined by 2-times (2 x) the standard cut-off and an optimal cut-off, as predictors of our two outcomes, aAb+ persistence and incident IA. Results 304 subjects (17.1%) tested aAb+; of those, 131 were IA-free and had at least one follow-up visit. Sixty-four per cent of these tested aAb+ again on their next visit. Anti-CCP+ at levels ≥2 x the standard cut-off was associated with 13-fold higher likelihood of aAb +persistence. During a median of 4.4 years (IQR: 2.2–7.2), 20 subjects (15.3%) developed IA. Among subjects that screened anti-CCP+ at ≥ 2 x or ≥an optimal cut-off, 32% and 26% had developed IA within 5 years, respectively. Both anti-CCP cut-offs conferred an approximate fourfold increased risk of future IA (HR 4.09 and HR 3.95, p Conclusions These findings support that aAb screening in a non-clinical setting can identify RA-related aAb+ individuals, as well as levels and combinations of aAbs that are associated with higher risk for future IA. Monitoring for the development of IA in aAb+ individuals and similar aAb testing approaches in at-risk populations may identify candidates for prevention studies in RA.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
tjr发布了新的文献求助30
1秒前
鱼遇发布了新的文献求助10
2秒前
香蕉觅云的应助被369ninja采纳,获得10
3秒前
兴文研究完成签到 ,获得积分10
3秒前
4秒前
4秒前
斯文败类的应助被qian采纳,获得10
4秒前
6秒前
按时毕业吧少年完成签到,获得积分10
6秒前
回去完成签到,获得积分10
7秒前
7秒前
7秒前
7秒前
上官若男的应助被暮雪采纳,获得30
8秒前
无花果的应助被苗条梨愁采纳,获得10
8秒前
2026221709发布了新的文献求助10
8秒前
bitter完成签到 ,获得积分10
8秒前
10秒前
田様的应助被ArArAr采纳,获得10
11秒前
12秒前
Lucas的应助被天空采纳,获得10
12秒前
12秒前
王某某发布了新的文献求助10
13秒前
13秒前
按时间好家伙完成签到,获得积分10
14秒前
NexusExplorer的应助被和谐的寒风采纳,获得10
15秒前
EstAffectus发布了新的文献求助10
15秒前
16秒前
bichumao完成签到,获得积分10
17秒前
qian发布了新的文献求助10
18秒前
19秒前
20秒前
21秒前
why完成签到,获得积分10
21秒前
GG完成签到,获得积分20
22秒前
22秒前
今后的应助被坚定的采波采纳,获得10
22秒前
orixero的应助被369ninja采纳,获得10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184462
求助须知:如何正确求助?哪些是违规求助? 9573447
关于积分的说明 21831674
捐赠科研通 7781651
什么是DOI,文献DOI怎么找? 3434363
关于科研通互助平台的介绍 2558468
邀请新用户注册赠送积分活动 2480923